OOIR: Observatory of International Research

Papers

(The H4-Index of Mucosal Immunology is 38. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Perturbation of the gut microbiome by Prevotella spp. enhances host susceptibility to mucosal inflammation	212
The central role of the nasal microenvironment in the transmission, modulation, and clinical progression of SARS-CoV-2 infection	162
The lung–gut axis during viral respiratory infections: the impact of gut dysbiosis on secondary disease outcomes	162
Human gut-associated lymphoid tissues (GALT); diversity, structure, and function	153
Animal and translational models of SARS-CoV-2 infection and COVID-19	142
Systemic and mucosal IgA responses are variably induced in response to SARS-CoV-2 mRNA vaccination and are associated with protection against subsequent infection	142
The intestinal neuro-immune axis: crosstalk between neurons, immune cells, and microbes	131
Cellular and functional heterogeneity of the airway epithelium	112
Introduction to host microbiome symbiosis in health and disease	95
Intestinal epithelial NAIP/NLRC4 restricts systemic dissemination of the adapted pathogen Salmonella Typhimurium due to site-specific bacterial PAMP expression	89
The impact of the lung environment on macrophage development, activation and function: diversity in the face of adversity	83
Dietary fiber metabolites regulate innate lymphoid cell responses	78
The NLRP6 inflammasome in health and disease	76
Tissue resident memory T cells in the respiratory tract	74
MAIT cells, guardians of skin and mucosa?	63
Neutrophils in respiratory viral infections	63
Long-term maintenance of lung resident memory T cells is mediated by persistent antigen	62
IL-17 production by tissue-resident MAIT cells is locally induced in children with pneumonia	60
Crosstalk between the oral microbiota, mucosal immunity, and the epithelial barrier regulates oral mucosal disease pathogenesis	54
Macrophage metabolic reprogramming during chronic lung disease	54
MAIT cell-directed therapy of Mycobacterium tuberculosis infection	54
A monoclonal antibody to Siglec-8 suppresses non-allergic airway inflammation and inhibits IgE-independent mast cell activation	53
Targeted deletion of the TSLP receptor reveals cellular mechanisms that promote type 2 airway inflammation	51
Seasonal and pandemic influenza: 100 years of progress, still much to learn	51
The emerging roles of eosinophils in mucosal homeostasis	51

Human small intestinal infection by SARS-CoV-2 is characterized by a mucosal infiltration with activated CD8+ T cells	50
Host/microbiota interactions in health and diseases—Time for mucosal microbiology!	50
Epithelium-autonomous NAIP/NLRC4 prevents TNF-driven inflammatory destruction of the gut epithelial barrier in Salmonella-infected mice	44
Gut-derived short-chain fatty acids modulate skin barrier integrity by promoting keratinocyte metabolism and differentiation	44
Microbiome-based interventions to modulate gut ecology and the immune system	44
The role of miR-155 in cigarette smoke-induced pulmonary inflammation and COPD	44
CD4+ T cells persist for years in the human small intestine and display a TH1 cytokine profile	42
Enteric neuroimmune interactions coordinate intestinal responses in health and disease	42
Granulocytes act as a niche for Mycobacterium tuberculosis growth	41
Dealing with a mucosal viral pandemic: lessons from COVID-19 vaccines	40
IL-22 receptor signaling in Paneth cells is critical for their maturation, microbiota colonization, Th17-related immune responses, and anti-Salmonella immunity	39
Uric acid pathway activation during respiratory virus infection promotes Th2 immune response via innate cytokine production and ILC2 accumulation	38
Host responses to mucosal biofilms in the lung and gut	38
IL-17A both initiates, via IFNγ suppression, and limits the pulmonary type-2 immune response to nematode infection	38